1. Induced Disease Models Products Anti-infection Autophagy
  2. Urinary System Disease Models Bacterial Autophagy Antibiotic
  3. Vancomycin

Vancomycin is an antibiotic for the treatment of bacterial infections.

For research use only. We do not sell to patients.

CAS No. : 1404-90-6

Size Price Stock Quantity
Free Sample (0.1 - 0.2 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
25 mg In-stock
50 mg In-stock
100 mg In-stock
1 g In-stock
5 g   Get quote  
10 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 94 publication(s) in Google Scholar

Other Forms of Vancomycin:

Top Publications Citing Use of Products

94 Publications Citing Use of MCE Vancomycin

WB
RT-PCR
IHC

    Vancomycin purchased from MedChemExpress. Usage Cited in: Redox Biol. 2023 Nov:67:102929.

    ARG2 protein expressions in the kidneys of Vancomycin (500 mg/kg, daily, 7 days, ip)-induced AKI mice.

    Vancomycin purchased from MedChemExpress. Usage Cited in: Redox Biol. 2023 Nov:67:102929.

    ARG2 mRNA expressions in the kidneys of Vancomycin (500 mg/kg, daily, 7 days, ip)-induced AKI mice.

    Vancomycin purchased from MedChemExpress. Usage Cited in: Redox Biol. 2023 Nov:67:102929.

    Representative images of immunohistochemistry staining of ARG2 in Vancomycin (500 mg/kg, daily, 7 days, ip)-induced AKI mice kidneys. The red arrows indicate deeper ARG2-positive staining of renal tubules. Scale, 20×, 100 μm, 40×, 50 μm.

    Vancomycin purchased from MedChemExpress. Usage Cited in: Redox Biol. 2023 Nov:67:102929.

    ARG2 protein expression in primary tubular epithelial cells treated by Vancomycin (4mM, 48 h).

    Vancomycin purchased from MedChemExpress. Usage Cited in: Redox Biol. 2023 Nov:67:102929.

    Renal function and renal tissue injury of ARG2 KO and WT mice administrated with Vancomycin were assessed by SCr, BUN, and tubular injury score. The red arrows showed the vacuolar degeneration, tubular necrosis, cast formation, and tubular dilation of renal tubules.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Vancomycin is an antibiotic for the treatment of bacterial infections.

    IC50 & Target

    Glycopeptide

     

    Cellular Effect
    Cell Line Type Value Description References
    CCRF-CEM IC50
    > 500 μM
    Compound: 1
    Inhibitory concentration against proliferation of human T-lymphocytic (CEM) cells
    Inhibitory concentration against proliferation of human T-lymphocytic (CEM) cells
    [PMID: 12801238]
    HEK-293T IC50
    > 320 μM
    Compound: Vancomycin
    Antiproliferative activity against HEK293T cells assessed as reduction in cell viability measured for 48 hrs by MTT assay
    Antiproliferative activity against HEK293T cells assessed as reduction in cell viability measured for 48 hrs by MTT assay
    [PMID: 38173250]
    HEK293 CC50
    > 100 μM
    Compound: Vancomycin
    Cytotoxicity against HEK293 cells after 72 hrs by MTT assay
    Cytotoxicity against HEK293 cells after 72 hrs by MTT assay
    [PMID: 24751446]
    HEK293 CC50
    > 100 μM
    Compound: Vancomycin
    Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 48 hrs by Alamar Blue reporter assay
    Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 48 hrs by Alamar Blue reporter assay
    [PMID: 30392371]
    HEK293 CC50
    > 1000 μg/mL
    Compound: Vancomycin
    Cytotoxicity against HEK293 cells after 72 hrs by MTT assay
    Cytotoxicity against HEK293 cells after 72 hrs by MTT assay
    [PMID: 24139168]
    L02 IC50
    > 20 μM
    Compound: Vancomycin
    Cytotoxicity against human LO2 cells
    Cytotoxicity against human LO2 cells
    [PMID: 33811991]
    L02 IC50
    > 30 μM
    Compound: Vancomycin
    Cytotoxicity against human L02 cells after 72 hrs by CCK-8 assay
    Cytotoxicity against human L02 cells after 72 hrs by CCK-8 assay
    [PMID: 35398730]
    L02 IC50
    > 43 μg/mL
    Compound: Vancomycin
    Cytotoxicity against human L02 cells after 72 hrs by CCK-8 assay
    Cytotoxicity against human L02 cells after 72 hrs by CCK-8 assay
    [PMID: 35398730]
    L02 IC50
    > 64 μg/mL
    Compound: Van
    Cytotoxicity against human L02 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay
    Cytotoxicity against human L02 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay
    [PMID: 38096652]
    L1210 IC50
    > 1000 μg/mL
    Compound: vancomycin
    Cytotoxicity against mouse L1210 cells assessed as cell viability by trypan blue assay
    Cytotoxicity against mouse L1210 cells assessed as cell viability by trypan blue assay
    [PMID: 9051915]
    L1210 IC50
    > 1000 μg/mL
    Compound: vancomycin
    Cytotoxicity against mouse L1210 cells by MTT assay
    Cytotoxicity against mouse L1210 cells by MTT assay
    [PMID: 9051915]
    L1210 IC50
    > 500 μM
    Compound: 1
    Inhibitory concentration of compound against proliferation of murine lukemia cells L1210 was determined
    Inhibitory concentration of compound against proliferation of murine lukemia cells L1210 was determined
    [PMID: 12801238]
    MOLT-4 IC50
    > 500 μM
    Compound: 1
    Inhibitory concentration of compound against proliferation of human T-lymphocytic cells MOLT-4/C8 was determined
    Inhibitory concentration of compound against proliferation of human T-lymphocytic cells MOLT-4/C8 was determined
    [PMID: 12801238]
    In Vitro

    Vancomycin is a large glycopeptide compound with a molecular weight of 1450 Da[1]. Vancomycin is a unique glycopeptide structurally unrelated to any currently available antibiotic. It also has a unique mode of action inhibiting the second stage of cell wall synthesis of susceptible bacteria. Vancomycin is active against a large number of species of Gram-positive bacteria, such as Staphylococcus aureus, Staph. epidermidis, Str. agalactiae, Str. bovis, Str. mutans, viridans streptococci, enterococci[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Note:
    Please do not refer to only one article to determine the experimental conditions. It is recommended to determine the optimal experimental conditions (animal strain, age, dosage, frequency and cycle, detection time and indicators, etc.) through preliminary experiments before the formal experiment.

    Vancomycin can be used to induce renal injury models[4].

    Induction of Kidney Injury Model[4]
    Background
    Vancomycin induces oxidative stress-related apoptosis in animals.
    Specific Modeling Methods
    Mice: C57BL/6 • male • 6-week-old
    Administration: 400 mg/kg • ip • once daily for 7 weeks
    Modeling Indicators
    Molecular changes: Induced cell apoptosis and increase in kidney Cr, BUN, MDA, IL-1β, IL-6, TNF-α, and NF-κB.

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: C57BL/6J male mice[4]
    Dosage: 400 mg/kg/day, 7 day
    Administration: Intraperitoneal injection (i.p.)
    Result: Caused renal injury with a higher renal injury score and kidney index.
    Induced cell apoptosis and increase in kidney Cr, BUN, MDA, IL-1β, IL-6, TNF-α, and NF-κB.
    Molecular Weight

    1449.25

    Formula

    C66H75Cl2N9O24

    CAS No.
    Appearance

    Solid

    Color

    White to light yellow

    Sequence

    {d-Leu}-{d-Tyr}-Asn-{d-Nty}-{d-Nty}-Tyr-{Nty} (Covalent bridge:Tyr2-Nty4, Nty4-Tyr6, Nty5-Nty7)

    Sequence Shortening

    {d-Leu}-{d-Tyr}-N-{d-Nty}-{d-Nty}-Y-{Nty} (Covalent bridge:Tyr2-Nty4, Nty4-Tyr6, Nty5-Nty7)

    SMILES

    O[C@@H]1[C@@H](O[C@@](O[C@@H](C)[C@H]2O)([H])C[C@@]2(N)C)[C@@H](O[C@H](CO)[C@H]1O)OC3=C(OC4=CC=C([C@H]([C@H]5NC([C@H](NC)CC(C)C)=O)O)C=C4Cl)C=C([C@](NC([C@@H](NC5=O)CC(N)=O)=O)([H])C(N[C@](C6=O)([H])C7=CC8=C(O)C=C7)=O)C=C3OC9=CC=C([C@H]([C@](C(N[C@@](C(O)=O)([H])C%10=C8C(O)=CC(O)=C%10)=O)([H])N6)O)C=C9Cl

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    4°C, sealed storage, away from moisture

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

    Solvent & Solubility
    In Vitro: 

    DMSO : 50 mg/mL (34.50 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 0.6900 mL 3.4501 mL 6.9001 mL
    5 mM 0.1380 mL 0.6900 mL 1.3800 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.08 mg/mL (1.44 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.08 mg/mL (1.44 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.39%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 0.6900 mL 3.4501 mL 6.9001 mL 17.2503 mL
    5 mM 0.1380 mL 0.6900 mL 1.3800 mL 3.4501 mL
    10 mM 0.0690 mL 0.3450 mL 0.6900 mL 1.7250 mL
    15 mM 0.0460 mL 0.2300 mL 0.4600 mL 1.1500 mL
    20 mM 0.0345 mL 0.1725 mL 0.3450 mL 0.8625 mL
    25 mM 0.0276 mL 0.1380 mL 0.2760 mL 0.6900 mL
    30 mM 0.0230 mL 0.1150 mL 0.2300 mL 0.5750 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Vancomycin
    Cat. No.:
    HY-B0671
    Quantity:
    MCE Japan Authorized Agent: